Suppression Therapy prior to elective Caesarean Section

Staphylococcus aureus is a common bacterium (germ) which can be found on the skin or in the nose of about a third of the population. Many normal healthy people have Staphylococcus aureus on their skin without causing them any harm. MRSA (Meticillin resistant Staphylococcus aureus) is a type of Staphylococcus aureus, which is resistant to the more commonly used antibiotics against Staphylococcus aureus associated infections. Most of the time skin is colonised with MSSA (Meticillin sensitive Staphylococcus aureus).

It is recommended that an MRSA/ MSSA suppression therapy is used prior to your caesarean section. The aim of the MRSA/ MSSA suppression therapy is to decrease the risk of wound infection by reducing the amount of MRSA/MSSA found on the skin.

Suppression Therapy prior to elective Caesarean Section icon

Suppression Therapy prior to elective Caesarean Section

File type: application/pdf Review date: February 2025